QUANTIFICAÇÃO DE IMUNOGLOBULINA ANTI-HBS EM ESTUDANTES DA SAÚDE PREVIAMENTE VACINADOS CONTRA HBV
Open Access
- 11 December 2024
- journal article
- Published by UNIVAP Universidade de Vale do Paraiba in Revista Univap
- Vol. 30 (68)
Abstract
It is estimated that 257 million people worldwide are infected with the hepatitis B virus (HBV). University students in the health field, due to their academic activities and future professions, are in a high-risk group. Vaccination against the virus is considered the most effective prophylactic method, and the state of immunity is characterized by the presence of immunoglobulin against the virus's surface antigen (HBsAg). This study aimed to assess the immunity status of 20 properly vaccinated undergraduate health students through the comparison of qualitative and quantitative methodologies. This study demonstrated that although all students had completed their vaccination schedules, 12 (60%) did not exhibit protective levels of antibodies, and discrepancies between methodologies indicated that rapid tests should not be used as the sole method for establishing a diagnosisKeywords
This publication has 16 references indexed in Scilit:
- Immunological Implications of Physical Inactivity among Older Adults during the COVID-19 PandemicGerontology, 2020
- Hepatitis B Vaccine and Immunoglobulin: Key ConceptsJournal of Clinical and Translational Hepatology, 2019
- Performance of rapid diagnostic tests for the detection of anti-HBs in various patient populationsJournal of Clinical Virology, 2017
- The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional StudyViral Immunology, 2016
- Causes, consequences, and reversal of immune system agingJournal of Clinical Investigation, 2013
- Prevenção das hepatites virais através de imunizaçãoJornal de Pediatria, 2006
- Long‐Term Protection against Carriage of Hepatitis B Virus after Infant VaccinationThe Journal of Infectious Diseases, 2006
- Waning Immunity To Plasma–Derived Hepatitis B Vaccine and the Need for Boosters 15 Years After Neonatal VaccinationHepatology, 2004
- Hepatitis B Vaccine: Current IssuesAnnals of Pharmacotherapy, 1997
- Reversible interaction of human lymphocytes with the mitogen concanavalin AExperimental Cell Research, 1970